CAROLINA RITTENHOUSE: Open Payments
NPI 1588021000 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 4 payments from 3 companies in 2025. Trend: 2023 $169 · 2024 $19 · 2025 $351
Consulting: $200Education: $151
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Actelion Pharmaceuticals US, Inc. | 1 | $100 |
| Merck Sharp & Dohme LLC | 2 | $51 |
Products named: Adempas, OPSUMIT, WINREVAIR.
Industry payments across TX — which companies pay providers there.
